Make a gift before the end of the year to drive research breakthroughs in 2026. 

Search

This is a podcast for neuroendocrine cancer patients and caregivers that presents expert information and patient perspectives.

Juventus Vs Psg May 2026

has shown strong momentum, recently defeating Angers 3-0 and Nantes 3-0 in league play, while also overcoming Liverpool in the Champions League quarter-finals.

PSG enters late April as the dominant force in Ligue 1, holding the top position with 69 points. In contrast, Juventus sits in fourth place in Serie A with 64 points, primarily focused on maintaining their Champions League qualification spot amidst a tight race with AC Milan. League Position Recent Form (All Competitions) 1st (Ligue 1) W, W, L, W, W Juventus 4th (Serie A) D, W, W, W, W Juventus vs PSG

is currently on an eight-match unbeaten streak in Serie A, characterized by a remarkably solid defense that has kept six clean sheets in their last seven matches. Their most recent outing was a 0-0 draw against AC Milan . Head-to-Head History has shown strong momentum, recently defeating Angers 3-0

As of April 2026, Paris Saint-Germain (PSG) and Juventus are in contrasting situations within their respective domestic and European campaigns. While PSG is preparing for a high-stakes Champions League semi-final against Bayern Munich on April 28, Juventus is navigating the final stretch of the Serie A season, currently fighting to secure a top-four finish. Current Form and League Standings League Position Recent Form (All Competitions) 1st (Ligue

Subscribe to our podcast:

Sign up to have NETRF notify you of the next NETWise podcast. Or, find and subscribe to NETWise on your favorite podcast service. 

Medical Disclaimer: This podcast is not intended as and shall not be relied upon as medical advice. The Neuroendocrine Tumor Research Foundation encourages all users to discuss any information found here with their oncologist, physician, and/or appropriate qualified health professional. Listening to this podcast does not constitute a patient-physician relationship. The Neuroendocrine Tumor Research Foundation does not represent that any information provided here should supplant the reasoned, informed advice of a patient’s oncologist, physician, or appropriate qualified health professional.